Affiliation:
1. Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil
Abstract
In the course of SARS-CoV-2 infection, the 3CL or nsp5 protease plays a pivotal role as the most important viral protease required for the maturation of viral proteins during host infection. Herein, we simulated for 500 ns 3CLproWT, 3CLproH41A, 3CLproBeta, and 3CLproOmicron, in complex with the substrates nsp 4|5 and nsp 5|6. Our results show that mutations in the 3CLpro present in the SARS-CoV-2 variants of concern (VOCs) did not lead to significant conformational changes or changes in substrate binding affinities. However, significantly high cleavage rates for the boundary between nsp4 and nsp5 were obtained for 3CLproBeta and 3CLproOmicron and may play a key role in viral replication and virus fitness gain. Our molecular dynamics data suggest that the cleavage rate of nsp4|5 may be related to the increased amount of viral load observed for these VOCs, releasing more nsp4 than other non-structural proteins. This study is limited by being fully computational. However, our results suggest that the cleavage rate may be affected by mutations. Based on our hydrogen bonding analyses, we also discovered that Gly143 and Glu166 are key residues in substrate recognition, suggesting that these residues may be incorporated as pharmacophoric centers for Beta and Omicron variants in drug design. Our results suggest that Gly143 and Glu166 are essential residues to interact with Gln6 of the different substrates and, therefore, are potential broad-spectrum pharmacophoric centers of SARS-CoV-2 3CLpro.
Funder
National Council for Scientific and Technological Development
the Coordination for the Improvement of Higher Education Personnel
São Paulo Research Foundation
Rede Virus MCTI
Geoambiente Sensoriamento Remoto LTDA
Reference61 articles.
1. De Souza, A.S., de Freitas Amorim, V.M., Guardia, G.D.A., Dos Santos, F.F., Ulrich, H., Galante, P.A.F., de Souza, R.F., and Guzzo, C.R. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains. Viruses, 14.
2. WHO (2023, April 15). WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/.
3. Community-Level Evidence for SARS-CoV-2 Vaccine Protection of Unvaccinated Individuals;Milman;Nat. Med.,2021
4. Modeling Vaccination Rollouts, SARS-CoV-2 Variants and the Requirement for Non-Pharmaceutical Interventions in Italy;Giordano;Nat. Med.,2021
5. Effectiveness of an Inactivated SARS-CoV-2 Vaccine;Mulholland;N. Eng. J. Med.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献